<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36231893</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Moderate, Little, or No Improvements in Neurobehavioral Symptoms among Individuals with Long COVID: A 34-Country Retrospective Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">12593</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph191912593</ELocationID><Abstract><AbstractText>(1) Background: Some people with COVID-19 develop a series of symptoms that last for several months after infection, known as Long COVID. Although these symptoms interfere with people's daily functioning and quality of life, few studies have focused on neurobehavioral symptoms and the risk factors associated with their development; (2) Methods: 1001 adults from 34 countries who had previously tested positive for COVID-19 completed the Neurobehavioral Symptom Inventory reporting the symptoms before their COVID-19 diagnosis, during the COVID-19 infection, and currently; (3) Results: Participants reported large-sized increases before vs. during COVID-19 in all domains. Participants reported a medium-sized improvement (during COVID-19 vs. now) in somatic symptoms, a small-sized improvement in affective symptoms, and very minor/no improvement in cognitive symptoms. The risk factors for increased neurobehavioral symptoms were: being female/trans, unemployed, younger age, low education, having another chronic health condition, greater COVID-19 severity, greater number of days since the COVID-19 diagnosis, not having received oxygen therapy, and having been hospitalized. Additionally, participants from North America, Europe, and Central Asia reported higher levels of symptoms across all domains relative to Latin America and Sub-Saharan Africa; (4) Conclusions: The results highlight the importance of evaluating and treating neurobehavioral symptoms after COVID-19, especially targeting the higher-risk groups identified. General rehabilitation strategies and evidence-based cognitive rehabilitation are needed in both the acute and Long COVID phases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramos-Usuga</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Biomedical Research Doctorate Program, University of the Basque Country, Barrio Sarriena, s/n, 48940 Leioa, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perrin</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><Identifier Source="ORCID">0000-0003-2070-215X</Identifier><AffiliationInfo><Affiliation>Department of Psychology, School of Data Science, University of Virginia, 400 Brandon Ave., #177, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdanova</LastName><ForeName>Yelena</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Physical Medicine &amp; Rehabilitation, VA Boston Healthcare System, 150 South Huntington Avenue, Boston, MA 02130, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Boston University School of Medicine, 72 E Concord St, Boston, MA 02118, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olabarrieta-Landa</LastName><ForeName>Laiene</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-8305-8720</Identifier><AffiliationInfo><Affiliation>Health Sciences Department, Public University of Navarre (UPNA), Catalu&#xf1;a, s/n, 31006 Pamplona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Sanitaria de Navarra (IdiSNA), 31008 Pamplona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzueta</LastName><ForeName>Elisabet</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-2770-2104</Identifier><AffiliationInfo><Affiliation>Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Fiona C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Center for Health Sciences, SRI International, 333 Ravenswood Ave, Menlo Park, CA 94025, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Physiology, Brain Function Research Group, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iacovides</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Physiology, Brain Function Research Group, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2000, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Mar</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2828-8504</Identifier><AffiliationInfo><Affiliation>Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, New York, NY 10029, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arango-Lasprilla</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-7184-8311</Identifier><AffiliationInfo><Affiliation>Departments of Psychology and Physical Medicine and Rehabilitation, Virginia Commonwealth University, 907 Floyd Ave, Richmond, VA 23284, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">neurobehavioral symptoms</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36231893</ArticleId><ArticleId IdType="pmc">PMC9564784</ArticleId><ArticleId IdType="doi">10.3390/ijerph191912593</ArticleId><ArticleId IdType="pii">ijerph191912593</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mahase E. COVID-19: What do we know about &#x201c;long COVID&#x201d;? BMJ. 2020;370:m2815. doi: 10.1136/bmj.m2815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. medRxiv. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J., Msika E.-F., Queneau M., Farid K., Paquet C. Long COVID: Cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J. Neurol. 2021;269:44&#x2013;46. doi: 10.1007/s00415-021-10655-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10655-x</ArticleId><ArticleId IdType="pmc">PMC8211714</ArticleId><ArticleId IdType="pubmed">34143277</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G., Bertelloni D., Diolaiuti F., Mucci F., Di Giuseppe M., Biella M., Gemignani A., Ciacchini R., Conversano C. Long-COVID Syndrome? A Study on the Persistence of Neurological, Psychological and Physiological Symptoms. Healthcare. 2021;9:575. doi: 10.3390/healthcare9050575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9050575</ArticleId><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020;16:636&#x2013;644. doi: 10.1038/s41582-020-0398-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0398-3</ArticleId><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M.U., Hanif M., Ali M.J., Haider M.A., Kherani D., Memon G.M., Karim A.H., Sattar A. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front. Neurol. 2020;11:518. doi: 10.3389/fneur.2020.00518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00518</ArticleId><ArticleId IdType="pmc">PMC7257377</ArticleId><ArticleId IdType="pubmed">32574248</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R., Banerjea A.C. Neurological Damage by Coronaviruses: A Catastrophe in the Queue! Front. Immunol. 2020;11:565521. doi: 10.3389/fimmu.2020.565521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.565521</ArticleId><ArticleId IdType="pmc">PMC7511585</ArticleId><ArticleId IdType="pubmed">33013930</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolen L.T., Mukerji S.S., Mejia N.I. Post-acute neurological consequences of COVID-19: An unequal burden. Nat. Med. 2022;28:20&#x2013;23. doi: 10.1038/s41591-021-01647-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01647-5</ArticleId><ArticleId IdType="pubmed">35039657</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews M.G., Mukhtar T., Eze U.C., Simoneau C.R., Ross J., Parikshak N., Wang S., Zhou L., Koontz M., Velmeshev D., et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes. bioRxiv. 2021 doi: 10.1101/2021.01.17.427024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.17.427024</ArticleId><ArticleId IdType="pmc">PMC9335272</ArticleId><ArticleId IdType="pubmed">35858406</ArticleId></ArticleIdList></Reference><Reference><Citation>IIsacson O. The Consequences of Coronavirus-Induced Cytokine Storm Are Associated With Neurological Diseases, Which May Be Preventable. Front. Neurol. 2020;11:745. doi: 10.3389/fneur.2020.00745.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00745</ArticleId><ArticleId IdType="pmc">PMC7393211</ArticleId><ArticleId IdType="pubmed">32793108</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirunpattarasilp C., James G., Freitas F., Sethi H., Kittler J.T., Huo J., Owens R.J., Attwell D. SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction. bioRxiv. 2021 doi: 10.1101/2021.04.01.438122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.04.01.438122</ArticleId><ArticleId IdType="pmc">PMC9384509</ArticleId><ArticleId IdType="pubmed">35867861</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236&#x2009;379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzakour L., Assal F., P&#xe9;ron J.A. Neuropsychological long-COVID: Neurologic or psychiatric origin? Rev. Med. Suisse. 2021;17:822&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">33908718</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak K.W., Johnsen S., Sattler S.M., Nielsen S., Kunalan K., Rungby J., Lapperre T., Porsberg C.M. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur. Neuropsychopharmacol. 2021;46:39&#x2013;48. doi: 10.1016/j.euroneuro.2021.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euroneuro.2021.03.019</ArticleId><ArticleId IdType="pmc">PMC8006192</ArticleId><ArticleId IdType="pubmed">33823427</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., Shi C., Hu S. The landscape of cognitive function in recovered COVID-19 patients. J. Psychiatr. Res. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Lewis A., Melmed K., Lin J., Kondziella D., Helbok R., Yaghi S., Meropol S., Wisniewski T., Balcer L., et al. Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States. Front. Aging Neurosci. 2021;13:690383. doi: 10.3389/fnagi.2021.690383.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.690383</ArticleId><ArticleId IdType="pmc">PMC8326803</ArticleId><ArticleId IdType="pubmed">34349633</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan K.A., Lurie J.K. Principal components analysis of the Neurobehavioral Symptom Inventory in a nonclinical civilian sample. Appl. Neuropsychol. Adult. 2017;24:522&#x2013;531. doi: 10.1080/23279095.2016.1216433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2016.1216433</ArticleId><ArticleId IdType="pubmed">27532246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lequerica A.H., Arango-Lasprilla J.C., Krch D. Factor analysis of the Neurobehavioral Symptom Inventory among a sample of Spanish-speakers. Neuropsychol. Rehabil. 2020;32:165&#x2013;178. doi: 10.1080/09602011.2020.1809464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602011.2020.1809464</ArticleId><ArticleId IdType="pubmed">32867569</ArticleId></ArticleIdList></Reference><Reference><Citation>King P.R., Donnelly K.T., Donnelly J.P., Dunnam M., Warner G., Kittleson C.J., Bradshaw C.B., Alt M., Meier S.T. Psychometric study of the Neurobehavioral Symptom Inventory. J. Rehabil. Res. Dev. 2012;49:879&#x2013;890. doi: 10.1682/JRRD.2011.03.0051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1682/JRRD.2011.03.0051</ArticleId><ArticleId IdType="pubmed">23299259</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicerone K.D., Kalmar K. Persistent postconcussion syndrome: The structure of subjective complaints after mild traumatic brain injury. J. Head Trauma Rehabil. 1995;10:1&#x2013;17. doi: 10.1097/00001199-199510030-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001199-199510030-00002</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans R.A., McAuley H., Harrison E.M., Shikotra A., Singapuri A., Sereno M., Elneima O., Docherty A.B., Lone N.I., Leavy O.C., et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): A UK multicentre, prospective cohort study. Lancet Respir. Med. 2021;9:1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health-Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciaszek J., Lenart M., Misiak B., Grzebieluch J., Gaw&#x142;owski P., Ciu&#x142;kowicz M., &#x141;uc D., Szcze&#x15b;niak D., Rymaszewska J. Unknown Enemy and Psychopathological Responses: A Cross-Sectional Nationwide Study Assessing the Knowledge About COVID-19. Front. Psychiatry. 2021;12:704558. doi: 10.3389/fpsyt.2021.704558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.704558</ArticleId><ArticleId IdType="pmc">PMC8385268</ArticleId><ArticleId IdType="pubmed">34456761</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., Horn C., Vanshylla K., Di Cristanziano V., Osebold L., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. Lancet Reg. Health-Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolakowsky-Hayner S.A., Goldin Y., Kingsley K., Alzueta E., Arango-Lasprilla J.C., Perrin P.B., Baker F.C., Ramos-Usuga D., Constantinidou F. Psychosocial Impacts of the COVID-19 Quarantine: A Study of Gender Differences in 59 Countries. Medicina. 2021;57:789. doi: 10.3390/medicina57080789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57080789</ArticleId><ArticleId IdType="pmc">PMC8400641</ArticleId><ArticleId IdType="pubmed">34440995</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacz F., Schmits E. Psychological distress during the COVID-19 lockdown: The young adults most at risk. Psychiatry Res. 2020;293:113486. doi: 10.1016/j.psychres.2020.113486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113486</ArticleId><ArticleId IdType="pmc">PMC7518205</ArticleId><ArticleId IdType="pubmed">33007682</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaiber P., Wen J.H., DeLongis A., Sin N.L. The Ups and Downs of Daily Life During COVID-19: Age Differences in Affect, Stress, and Positive Events. J. Gerontol. Ser. B. 2021;76:e30&#x2013;e37. doi: 10.1093/geronb/gbaa096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbaa096</ArticleId><ArticleId IdType="pmc">PMC7454856</ArticleId><ArticleId IdType="pubmed">32674138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolakowsky-Hayner S.A., Shen J., Goldin Y., Kingsley K., Alzueta E., Arango-Lasprilla J.C., Perrin P.B., Baker F.C., Constantinidou F., Bogdanova Y. The COVID-19 Pandemic: Age Differences in Sleep Quality and Mental Health Across 59 Countries. Epidemiol. Public Health Res. 2021;18:22&#x2013;26.</Citation></Reference><Reference><Citation>Bruine de Bruin W. Age Differences in COVID-19 Risk Perceptions and Mental Health: Evidence From a National U.S. Survey Conducted in March 2020. J. Gerontol. Ser. B. 2021;76:e24&#x2013;e29. doi: 10.1093/geronb/gbaa074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbaa074</ArticleId><ArticleId IdType="pmc">PMC7542924</ArticleId><ArticleId IdType="pubmed">32470120</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearman A., Hughes M.L., Smith E.L., Neupert S.D. Age Differences in Risk and Resilience Factors in COVID-19-Related Stress. J. Gerontol. Ser. B. 2021;76:e38&#x2013;e44. doi: 10.1093/geronb/gbaa120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronb/gbaa120</ArticleId><ArticleId IdType="pmc">PMC7454933</ArticleId><ArticleId IdType="pubmed">32745198</ArticleId></ArticleIdList></Reference><Reference><Citation>Carstensen L.L., Shavit Y.Z., Barnes J.T. Age Advantages in Emotional Experience Persist Even Under Threat From the COVID-19 Pandemic. Psychol. Sci. 2020;31:1374&#x2013;1385. doi: 10.1177/0956797620967261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0956797620967261</ArticleId><ArticleId IdType="pubmed">33104409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong B.L., Luo W., Li H.M., Zhang Q.Q., Liu X.G., Li W.T., Li Y. Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: A quick online cross-sectional survey. Int. J. Biol. Sci. 2020;16:1745&#x2013;1752. doi: 10.7150/ijbs.45221.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.45221</ArticleId><ArticleId IdType="pmc">PMC7098034</ArticleId><ArticleId IdType="pubmed">32226294</ArticleId></ArticleIdList></Reference><Reference><Citation>PPierre M., Keller M., Altschul D., Fawns-Ritchie C., Hartley L., Nangle C., Edwards R., Dawson R., Campbell A., Flaig R., et al. Socioeconomic position and mental health during the COVID-19 pandemic: A cross-sectional analysis of the COVIDLife study. Wellcome Open Res. 2021;6:139. doi: 10.12688/wellcomeopenres.16820.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16820.1</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachtler B., Michalski N., Nowossadeck E., Diercke M., Wahrendorf M., Santos-H&#xf6;vener C., Lampert T., Hoebel J. Socioeconomic inequalities and COVID-19&#x2014;A review of the current international literature. J. Health Monit. 2020;5((Suppl. 7)):3&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8734114</ArticleId><ArticleId IdType="pubmed">35146298</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S., Lau A., So H.C. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits. Diabetes Care. 2020;43:1416&#x2013;1426. doi: 10.2337/dc20-0643.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0643</ArticleId><ArticleId IdType="pubmed">32430459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q., Meng M., Kumar R., Wu Y., Huang J., Lian N., Deng Y., Lin S. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J. Med. Virol. 2020;92:1915&#x2013;1921. doi: 10.1002/jmv.25889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25889</ArticleId><ArticleId IdType="pmc">PMC7262275</ArticleId><ArticleId IdType="pubmed">32293753</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8:e21. doi: 10.1016/S2213-2600(20)30116-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020;17:259&#x2013;260. doi: 10.1038/s41569-020-0360-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Cao Y., Xu S., Zhou M. Reply to Comments on &#x201c;Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China&#x201d;. J. Med. Virol. 2020;92:1417&#x2013;1418. doi: 10.1002/jmv.25838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25838</ArticleId><ArticleId IdType="pmc">PMC7262272</ArticleId><ArticleId IdType="pubmed">32266995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz H., Alsrhani A., Zafar A., Javed H., Junaid K., Abdalla A.E., Abosalif K.O., Ahmed Z., Younas S. COVID-19 and comorbidities: Deleterious impact on infected patients. J. Infect. Public Health. 2020;13:1833&#x2013;1839. doi: 10.1016/j.jiph.2020.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.014</ArticleId><ArticleId IdType="pmc">PMC7402107</ArticleId><ArticleId IdType="pubmed">32788073</ArticleId></ArticleIdList></Reference><Reference><Citation>Daste C., Ficarra S., Dumitrache A., Cariou A., Lef&#xe8;bvre A., P&#xe8;ne F., Roche N., Roren A., Thery C., Vidal J., et al. Post-intensive care syndrome in patients surviving COVID-19. Ann. Phys. Rehabil. Med. 2021;64:101549. doi: 10.1016/j.rehab.2021.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2021.101549</ArticleId><ArticleId IdType="pmc">PMC8233854</ArticleId><ArticleId IdType="pubmed">34182168</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;Em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Senniappan K., Jeyabalan S., Rangappa P., Kanchi M. Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19? Indian J. Anaesth. 2020;64:835&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7791429</ArticleId><ArticleId IdType="pubmed">33437070</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliaei S., SeyedAlinaghi S., Mehrtak M., Karimi A., Noori T., Mirzapour P., Shojaei A., MohsseniPour M., Mirghaderi S.P., Alilou S., et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): A systematic review. Eur. J. Med. Res. 2021;26:96. doi: 10.1186/s40001-021-00570-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00570-2</ArticleId><ArticleId IdType="pmc">PMC8374420</ArticleId><ArticleId IdType="pubmed">34412709</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Health Metrics and Evaluation  Global Health Data Exchange (GHDx) 2021.  [(accessed on 15 September 2021)].  Available online:  http://ghdx.healthdata.org/gbd-results-tool?params=gbd-api-2019-permalink/d780dffbe8a381b25e1416884959e88b.</Citation></Reference><Reference><Citation>Mar&#xed;-Dell&#x2019;Olmo M., Gotsens M., Pasar&#xed;n M., Rodr&#xed;guez-Sanz M., Artazcoz L., de Olalla P.G., Rius C., Borrell C. Socioeconomic Inequalities in COVID-19 in a European Urban Area: Two Waves, Two Patterns. Int. J. Environ. Res. Public Health. 2021;18:1256. doi: 10.3390/ijerph18031256.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18031256</ArticleId><ArticleId IdType="pmc">PMC7908269</ArticleId><ArticleId IdType="pubmed">33573323</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>